Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension

Autor: Sinha, Smeeta, Nigwekar, Sagar U., Brandenburg, Vincent, Gould, Lisa J., Serena, Thomas E., Moe, Sharon M., Aronoff, George R., Chatoth, Dinesh K., Hymes, Jeffrey L., Carroll, Kevin J., Alperovich, Gabriela, Keller, Laurence H., Perelló, Joan, Gold, Alex, Chertow, Glenn M.
Zdroj: In eClinicalMedicine September 2024 75
Databáze: ScienceDirect